USPTO serial 79281247
ACROPASS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 21, 2021
- Examiner
- SPARACINO, MARK V
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ACROPASS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
April L. Besl
April L. Besl Dinsmore & Shohl LLP255 E. Fifth Street, Suite 1900Cincinnati, OH 45202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Gel eye masks; anti-aging non-medicated skin care preparations; non-medicated toiletry preparations; toiletry preparations, namely, toothpaste, bar soap; skin moisturizer masks; cosmetic patches containing sunscreen and sun block for use on the skin; cosmetic preparations for skin care; phytocosmetic preparations; cosmetics for personal use; wrinkle removing skin care preparations; facial packs, namely, facial cleansers, scrubs, washes and moisturizers; wrinkle-minimizing cosmetic preparations for topical facial use; skin whitening preparations; cosmetic preparations for skin renewal; gel eye patches for cosmetic purposes; beauty masks; skin masks for cosmetic use; eye gels for cosmetic use; cosmetic facial masks; cosmetics | ACTIVE | — |
| 005 | Pharmaceutical preparations for health care, namely, for the treatment of skin; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating diabetes; anti-motion sickness agents; non-prescription medicines, namely, microneedles for treatment of skin; vitamin supplement patches; pharmacological preparations for skin care; skin patches for the transdermal delivery of pharmaceuticals; transdermal patches for use in the treatment of skin; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films, coatings for tablets, that facilitate the delivery of pharmaceutical preparations; medical and surgical plasters; medicated compresses; drugs for medical purposes, namely, for the treatment of skin; plasters for medical purposes; pharmaceuticals for treatment of skin; medicines for human purposes, namely, for the treatment of skin; pharmaceutical preparations for skin care; medicated preparations for skin treatment; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for use in smoking cessation | ACTIVE | — |
| 010 | Medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for facilitating the inhalation of pharmaceutical preparations; applicators for pharmaceutical preparations, namely, drug delivery patches sold without medication; injection device for pharmaceuticals; apparatus for acne treatment; medical instruments for use in general surgery; cases fitted for medical instruments; medical apparatus and instruments for use in general surgery; needles for medical purposes; medical x-ray apparatus; fluid injectors for medical purposes; injection needles for medical use; medical instruments for application in human bodies, namely, for use in treating skin disease; disposable syringes; injection needles; medical apparatus, namely, infusion and injection devices for administering drugs for therapeutic purposes; injection instruments without needles; medication injectors for fluid medications; implantable subcutaneous drug delivery, namely, pumps, ports; hypodermic syringes and needles | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RAPHAS Co., Ltd.
- Other trademarks owned by RAPHAS Co., Ltd.
- Other trademarks owned by RAPHAS Co., Ltd.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named ACROPASS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 25, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 25, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 24, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 30, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 27, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 4, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 3, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 21, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 21, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 11, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 5, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 5, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 15, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 15, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 15, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 10, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 27, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 25, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 23, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 23, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 17, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 22, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 22, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 22, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 22, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 22, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 22, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 23, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 23, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 20, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 19, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 31, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |